Plenco 15190

Product Description

Plenco 15190 was a phenolic molding compound manufactured by Plastics Engineering Company, commonly known as Plenco, a Wisconsin-based manufacturer with a long history in thermosetting plastics production. Phenolic compounds of this type belong to a broader family of synthetic resins derived from the reaction of phenol with formaldehyde, a chemistry pioneered in the early twentieth century that gave rise to some of the most widely used industrial molding materials of the modern era.

Plenco developed and marketed a range of phenolic molding compounds intended for industrial applications where heat resistance, electrical insulation, dimensional stability, and mechanical strength were required. The 15190 formulation was part of this product line, designed to meet the demanding performance requirements of industrial manufacturing environments. Phenolic compounds like Plenco 15190 were used in the production of molded components including housings, handles, electrical parts, and other formed pieces that needed to withstand elevated temperatures or mechanical stress in service.

Plastics Engineering Company operated as a specialty materials supplier, providing molding compounds to manufacturers across multiple industrial sectors. The company’s products were used by fabricators and molders who processed raw compound into finished components, placing industrial workers directly in contact with the material during its manufacture, handling, and processing stages.

Asbestos Content

Phenolic molding compounds produced during much of the twentieth century frequently incorporated asbestos as a functional filler. Asbestos fibers were valued in these formulations because they contributed meaningfully to the mechanical and thermal properties that made phenolic compounds commercially desirable. Specifically, asbestos enhanced heat resistance, improved dimensional stability under thermal cycling, added tensile and flexural strength to molded parts, and helped the compound resist cracking or warping during and after the molding process.

Litigation records document that Plenco 15190 was alleged to have contained asbestos as a component material. Plaintiffs alleged that the formulation incorporated asbestos fibers consistent with industry-wide practices for phenolic molding compounds during the relevant periods of production and use. The specific fiber types used in phenolic compound formulations of this era included chrysotile and, in some formulations, amphibole varieties, depending on the performance requirements and sourcing practices of the manufacturer at a given time.

The presence of asbestos in phenolic molding compounds was not disclosed to downstream users, fabricators, or workers in any systematic way during much of the period these materials were in commercial use. Safety data and hazard communication practices that are standard today were largely absent during the decades when asbestos-containing molding compounds like Plenco 15190 were being processed on factory floors.

How Workers Were Exposed

Industrial workers who handled, processed, or worked in proximity to Plenco 15190 and similar phenolic molding compounds faced potential asbestos fiber exposure through several recognized pathways.

Molding operations represented a primary exposure pathway. When phenolic compound was loaded into compression or transfer molds, subjected to heat and pressure, and then removed as a finished part, dust and particulate were generated at multiple points in the cycle. Workers operating molding presses, loading raw compound, removing finished parts, and cleaning molds were positioned directly within the zone where airborne particulate could be released.

Finishing operations created additional exposure risk. Molded phenolic parts routinely required trimming, deflashing, drilling, grinding, sanding, or polishing to meet dimensional or surface finish specifications. These mechanical operations on cured phenolic material could release fine dust that, if the base compound contained asbestos, would carry asbestos fibers into the breathing zone of workers performing or working near those tasks.

Material handling prior to molding also contributed to exposure potential. Phenolic molding compound in its raw form was typically supplied as a granular or powder material. Weighing, transferring, and loading this material generated dust that could remain airborne for extended periods in the relatively enclosed environments of industrial production facilities.

Litigation records document that plaintiffs alleged repeated and prolonged exposure to airborne dust during the course of routine job duties involving Plenco 15190 and related phenolic compounds. Industrial workers generally, including press operators, finishing workers, maintenance personnel, and others present in the manufacturing environment, were identified in legal proceedings as populations whose work brought them into regular contact with these materials.

Ventilation in industrial molding facilities during much of the period these compounds were in use was often inadequate by modern standards, and respiratory protection for workers handling dusty materials was inconsistently provided or enforced. These conditions, plaintiffs alleged, allowed asbestos fiber concentrations to accumulate in work areas over extended periods.

Asbestos-related diseases associated with occupational exposure include mesothelioma, lung cancer, asbestosis, and other pulmonary conditions. These diseases characteristically have long latency periods, often measured in decades, meaning that workers exposed to asbestos-containing materials during their working years may not develop symptoms or receive a diagnosis until many years after the exposure occurred.

Plenco 15190 is a Tier 2 product for purposes of asbestos litigation. There is no dedicated asbestos bankruptcy trust fund established specifically for claims arising from Plenco or Plastics Engineering Company products. Legal remedies for individuals injured by exposure to this product have been pursued through civil litigation in state and federal courts.

Litigation records document that claims have been filed by plaintiffs alleging that exposure to Plenco 15190 and related Plenco phenolic compounds caused asbestos-related disease. Plaintiffs alleged that the manufacturer knew or should have known of the hazards associated with asbestos-containing molding compounds and failed to provide adequate warnings to workers or downstream users about those hazards.

Individuals who were diagnosed with mesothelioma, lung cancer, asbestosis, or other asbestos-related conditions following occupational exposure to Plenco 15190 may have legal options available to them. Because industrial workplaces commonly used multiple asbestos-containing products simultaneously, claims arising from phenolic compound exposure often involve multiple defendants, including manufacturers of other materials used in the same work environment.

Anyone who believes they may have a claim related to Plenco 15190 exposure should consult with an attorney experienced in asbestos litigation. Key information that supports these cases typically includes employment history, job duties, identification of specific products handled, facility names, and dates of exposure. Medical documentation of diagnosis and the attending physician’s assessment of causation are also central to any legal claim.

The latency characteristics of asbestos-related disease mean that statutes of limitations in asbestos cases are generally measured from the date of diagnosis rather than the date of exposure, but specific rules vary by jurisdiction. Prompt consultation with qualified legal counsel is advisable to ensure that applicable deadlines are identified and preserved.

This article is provided for informational purposes and documents publicly available information drawn from litigation records and regulatory sources. It does not constitute legal or medical advice.